0001144204-16-124265.txt : 20160916
0001144204-16-124265.hdr.sgml : 20160916
20160916161524
ACCESSION NUMBER: 0001144204-16-124265
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160915
FILED AS OF DATE: 20160916
DATE AS OF CHANGE: 20160916
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EYEGATE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001372514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 271 WAVERLEY OAKS ROAD
STREET 2: SUITE 108
CITY: WALTHAM
STATE: MA
ZIP: 02452
BUSINESS PHONE: 781-788-9043
MAIL ADDRESS:
STREET 1: 271 WAVERLEY OAKS ROAD
STREET 2: SUITE 108
CITY: WALTHAM
STATE: MA
ZIP: 02452
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FROM STEPHEN
CENTRAL INDEX KEY: 0001620137
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36672
FILM NUMBER: 161889574
MAIL ADDRESS:
STREET 1: C/O BURNS & LEVINSON LLP
STREET 2: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
v448959_4.xml
OWNERSHIP DOCUMENT
X0306
4
2016-09-15
0
0001372514
EYEGATE PHARMACEUTICALS INC
EYEG
0001620137
FROM STEPHEN
C/O EYEGATE PHARMACEUTICALS, INC.
271 WAVERLEY OAKS ROAD, SUITE 108
WALTHAM
MA
02452
1
1
0
0
President and CEO
Common Stock
2016-09-15
4
P
0
15000
1.4892
A
139965
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.479 to $1.509, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
/s/ J. Fraser Collin, attorney-in-fact
2016-09-16